Ceeli Thairianathan: Bridging Biotechnology and Clinical Application
Ceeli Thairianathan, Northeastern Graduate Student, shared a post on LinkedIn:
“Bridging Biotechnology and Clinical Application: Key Insights from Biocytogen
As a biotechnology graduate student, I recently attended a webinar by Biocytogen on the critical role of humanized models in navigating the complexities of cardio-metabolic drug discovery.
Here is a concise technical summary of the platform’s capabilities:
1. Next-Gen Anticoagulation:
Biocytogen is utilizing B-hFXI and B-hFXII plus mice to target the intrinsic coagulation pathway.
This strategy aims to uncouple dangerous thrombosis from essential physiological hemostasis.
2. Precision Cardiomyopathy Models:
The B-Mybpc3 KO model demonstrates high phenotypic fidelity to human disease, exhibiting cardiac enlargement and ventricular wall thickening.
Masson-staining in 17-week-old models provides clear evidence of endocardial collagen fiber proliferation.
3. Systemic Metabolic Solutions:
Advanced multi-target models, such as the B-hLPA/hAPOB/hPCSK9 plus mice, are engineered to evaluate therapies for atherosclerosis and hyperlipidemia.
The broader portfolio addresses NAFLD/MASH, Hyperuricemia, and Diabetic Nephropathy.
4. Integrated Assay Platform:
Beyond the models, Biocytogen provides a robust analytical framework including MSD, FACS, and Luminex to support comprehensive PK/PD/Tox/MoA studies.
These integrated preclinical solutions are essential for accelerating the transition from laboratory research to successful IND filing.
I am grateful for the expert insights shared during this session, which underscored the importance of humanized precision in modern drug discovery.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital